Triple
T2138540
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Lucentis |
E46708
|
entity |
| Predicate | hasGenericName |
P23148
|
FINISHED |
| Object |
ranibizumab
Ranibizumab is a monoclonal antibody fragment used primarily as an intravitreal injection to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
|
E46708
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a88a174ab48190a5db20c132e5dccf |
elicitation | completed |
| NER | batch_69abbe012aa481909ffa0a50e58efabb |
ner | completed |
| NED1 | batch_69ae51b1290c8190a08850b428c99a6c |
ned_source_triple | completed |
| NED2 | batch_69ae55fdc32c8190b6ecdc9b23d64cc5 |
ned_description | completed |
| NEDg | batch_69ae55923b748190bf7a2df3ae94edc8 |
nedg | completed |
Created at: March 4, 2026, 7:44 p.m.